Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ABBV

3 Blue-Chip Stocks to Make Sure You Own in 2023

Despite the ever-expanding list of tech layoffs due to macroeconomic headwinds, a few fundamentally strong businesses are well-positioned to maintain their growth trajectory in the foreseeable future. Therefore, loading up on stocks of three such wonderful businesses, AbbVie (ABBV), Broadcom (AVGO), and Verizon (VZ), available at fair prices, could set…

StockNews.com

3 High-Quality Stocks That Can Help Take Your Portfolio to the Next Level

With encouraging economic data discouraging investors, the market is unlikely to stabilize anytime soon. Therefore, loading up on fundamentally strong stocks AbbVie (ABBV), Gartner (IT), and Dropbox (DBX) could keep portfolios buoyant and generate alpha in an otherwise chronic bear market. Continue reading….

StockNews.com

2 Health Care Stocks You Can't Go Wrong with Buying Right Now

Government funding for the healthcare industry is increasing significantly. Additionally, progressions in hospitals’ digital architecture and a surge in telemedicine brought on by the convergence of the COVID-19 pandemic and 5G networks are further boosting the industry’s growth. Hence, investing in fundamentally strong healthcare stocks AbbVie (ABBV) and Cardinal Health…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

StockNews.com

4 Warren Buffett Stocks to Buy and Never Sell

Legendary investor Warren Buffett’s holding company Berkshire Hathaway has outperformed the broader market over the past year. His investment portfolio has been a guide for several long-term investors for decades. Amid a highly uncertain market and economic backdrop, Warren Buffett holdings Procter & Gamble (PG), AbbVie (ABBV), Biogen (BIIB), and…

StockNews.com

3 High-Yield Dividend Stocks to Buy Now to Retire Rich

Even though inflation seems to be cooling down, the Fed expects the interest rate hikes to continue in the near term. As market volatility is expected to remain, high-yielding dividend stocks AbbVie (ABBV), Sisecam Resources (SIRE), and Bassett Furniture (BSET) could be wise buys now. These stocks could help you…

StockNews.com

3 Stocks You Shouldn't Wait Any Longer to Buy

With slowing inflation, indications of slower rate hikes by the Fed beginning this month, and resilient employment growth, fundamentally strong stocks AbbVie (ABBV), Oracle Corporation (ORCL), and McKesson (MCK) could be opportune investments now. Continue reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

2 Top Medical Stocks to Buy and Hold for the Long Term

While the stock market has been under pressure this year, medical stocks have remained resilient due to the inelastic demand for their offerings. Moreover, the demand for medical goods and services is rising amid increasing health awareness and chronic diseases. Given the solid prospects of the industry, fundamentally sound medical…

StockNews.com

3 Dividend Aristocrats to Buy Now for a Lifetime of Passive Income

The stock market has experienced wild swings this year amid the Fed’s battle to curb the multi-decade high inflation levels with its stringent interest rate hikes. This has raised recession fears, and many economists now foresee an economic downturn. Amid the market turbulence, investors could buy dividend aristocrats AbbVie (ABBV),…

StockNews.com

3 Bold Stocks to Buy Hand Over Fist Right Now

While the impact of further rate hikes has been majorly factored into the stock market, it could be wise to invest in fundamentally sound stocks AbbVie (ABBV), AT&T (T), and Molina Healthcare (MOH) to tide over any possible the turbulences. Continue reading….

StockNews.com

3 Stocks You Won't Regret Buying in December 2022

The Fed Chairman recently indicated a slower pace of rate increases. However, many analysts still believe the economy will face a mild recession next year. Therefore, it could be wise to invest in quality stocks with solid growth prospects, such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Lifeway Foods (LWAY).…

StockNews.com

5 Stocks Investors Can Hold Onto Forever

Although the stock market remains highly volatile due to high inflation levels and the Fed’s aggressive monetary policy stance, analysts believe consumer prices will significantly decline in 2023. Moreover, the Fed also signaled slower rate hikes ahead. So, fundamentally strong stocks, AbbVie (ABBV), CSX Corporation (CSX), Waste Management (WM), Stellantis…

StockNews.com

3 Health Care Stocks That Are No-Brainer Buys Right Now

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

StockNews.com

2 Strong Health Care Stocks to Add to Your Portfolio Now

The global healthcare industry is showing robust growth prospects with the growing adoption of advanced technologies, rising health awareness, and increasing chronic diseases. Amid rising spending on medicines, fundamentally strong healthcare stocks AbbVie (ABBV) and Bristol-Myers Squibb (BMY) might be ideal additions to your portfolio now. Read on.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 No-Brainer Stock to Buy That Could Help You Retire Earlier

Biopharma giant AbbVie (ABBV) is well-placed to gain from its drug pipeline, recent drug approvals, and strategic acquisitions. Given its strong fundamentals, discounted valuation, high profitability, reliable dividends, and favorable analyst estimates, investing in this stock could help you retire earlier. Read more.

StockNews.com

Hot Stocks to Buy? 3 Medical Stocks to Consider Now

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…

StockNews.com

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

Benzinga

AbbVie Unusual Options Activity For October 28

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 13 strange trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Is What Whales Are Betting On AbbVie

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 13 strange trades.

StockNews.com

4 Stocks to Help You Navigate a Bear Market

Amid sky-high inflation and consecutive big rate hikes, recessionary fears are looming. We believe fundamentally sound and stable dividend-paying stocks Walmart (WMT), AbbVie (ABBV), Coca-Cola Company (KO), and International Paper Company (IP) could be ideal investments to navigate a bear market. Read more.

StockNews.com

5 Stocks Investors Can Count on in a Bear Market

The stock market is expected to remain under pressure as the Fed continues its hawkish stance to fight inflation. Moreover, the International Monetary Fund has recently warned of elevated global financial stability risk. We think fundamentally solid stocks UnitedHealth Group (UNH), Walmart (WMT), AbbVie (ABBV), Coca-Cola Company (KO), and Dollar…

StockNews.com

3 Stocks to Buy Now and Never Sell

Raging inflation and the Fed’s continued rate hikes have kept the stock market under tremendous pressure. Healthcare stocks have always been considered safe haven amid market uncertainties, and we think fundamentally solid stocks AbbVie (ABBV), Pfizer (PFE), and McKesson Corporation (MCK) could be ideal buys for the long term. Read…

StockNews.com

3 Safe Stocks You'll Want to Have Exposure to in 2022

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

Benzinga

Check Out What Whales Are Doing With ABBV

Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

StockNews.com

5 Blue Chip Stocks to Help You Beat the Market Slump

Rising concerns over stubbornly-high inflation and the Fed’s commitment to bring it down to its desired level have kept equities under pressure lately. Amid increasing recessionary concerns, investing in blue-chip stocks such as Procter & Gamble (PG), AbbVie (ABBV), Pfizer (PFE), Dow (DOW), and Walgreens Boots Alliance (WBA) could help…

1 … 4 5 6 7

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

Sristi Suman Jayaswal

90 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.